Hypothalamic-pituitary-adrenal system function in patients with alzheimer's disease

[1]  D. Swaab,et al.  Similar Age Related Increase of Vasopressin Colocalization in Paraventricular Corticotropin‐Releasing Hormone Neurons in Controls and Alzheimer Patients , 1994, Journal of neuroendocrinology.

[2]  I. Heuser,et al.  Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender , 1994, Neurobiology of Aging.

[3]  D. Oorschot,et al.  Age‐related increase in the total number of corticotropin‐releasing hormone neurons in the human paraventricular nucleus in controls and alzheimer's disease: Comparison of the disector with an unfolding method , 1994, The Journal of comparative neurology.

[4]  S. Maier,et al.  Blockade of the hypothalamic-pituitary-adrenal response to stress by intraventricular injection of dexamethasone: A method for studying the stress-induced peripheral effects of glucocorticoids , 1993, Psychoneuroendocrinology.

[5]  J. Price,et al.  The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys , 1993, The Journal of comparative neurology.

[6]  R. Ravid,et al.  Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin , 1993, Brain Research.

[7]  J. Rowe,et al.  The pituitary-adrenal glucocorticoid response is altered by gender and disease. , 1993, Journal of gerontology.

[8]  D. Jezova,et al.  Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus , 1992, Brain Research.

[9]  E. D. Kloet,et al.  Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: Neuroendocrine activity and corticosteroid receptors , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  L. Squire,et al.  Inhibition of glucocorticoid secretion by the hippocampal formation in the primate , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  E. Holsboer-trachsler,et al.  Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression , 1991, Psychiatry Research.

[12]  M. Zaudig,et al.  SIDAM – A Structured Interview for the diagnosis of Dementia of the Alzheimer type, Multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R , 1991, Psychological Medicine.

[13]  I. Ferrier,et al.  Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression , 1990, Biological Psychiatry.

[14]  E. Fliers,et al.  The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease , 1990, Neurobiology of Aging.

[15]  R. Sapolsky,et al.  Hypercortisolism and its possible neural bases , 1990, Biological Psychiatry.

[16]  R. Handa,et al.  Neurochemical, endocrine and immunological responses to stress in young and old Fischer 344 male rats , 1990, Neurobiology of Aging.

[17]  F. Holsboer,et al.  Cortisol Response to a Combined Dexamethasone‐Human Corticotrophin‐Releasing Hormone Challenge in Patients with Depression , 1989, Journal of neuroendocrinology.

[18]  H. Akil,et al.  Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  I. Heuser,et al.  Neuroendocrine functions in Alzheimer's disease patients , 1989 .

[20]  E. R. Kloet,et al.  Neurotrophic ACTH analogue promotes plasticity of type I corticosteroid receptor in brain of senescent male rats , 1988, Neurobiology of Aging.

[21]  A. Heyman,et al.  Depression in early-onset Alzheimer's disease: Clinical and neuroendocrine correlates , 1988, Biological Psychiatry.

[22]  J. V. Van eekelen,et al.  Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus , 1988, Journal of neuroscience research.

[23]  B. McEwen,et al.  ABNORMAL CORTISOL RESPONSE IN ALZHEIMER'S DISEASE LINKED TO HIPPOCAMPAL ATROPHY , 1988, The Lancet.

[24]  G. Fink,et al.  Effects of adrenalectomy and glucocorticoids on the peptides CRF‐41, AVP and oxytocin in rat hypophysial portal blood. , 1988, The Journal of physiology.

[25]  Paul D. Coleman,et al.  Neuron numbers and dendritic extent in normal aging and Alzheimer's disease , 1987, Neurobiology of Aging.

[26]  D. Price,et al.  Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy , 1987, Neurology.

[27]  S. Rapoport,et al.  Cerebrospinal fluid concentrations of corticotropin‐releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease , 1987, Neurology.

[28]  F. Holsboer,et al.  Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression Implications for pathophysiology of DST nonsuppression , 1987, Biological Psychiatry.

[29]  Joseph B. Martin,et al.  Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations , 1986, Annals of neurology.

[30]  T. O'donohue,et al.  Spinal fluid CRF reduction in Alzheimer's disease , 1986, Neuropeptides.

[31]  B. McEwen,et al.  Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.

[32]  K. Davis,et al.  Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms. , 1986, The American journal of psychiatry.

[33]  K. Davis,et al.  Cortisol and Alzheimer's disease, I: Basal studies. , 1986, The American journal of psychiatry.

[34]  D. Price,et al.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease , 1986, Nature.

[35]  G. Reynolds,et al.  Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. , 1985, JAMA.

[36]  E. R. Kloet,et al.  Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. , 1985, Endocrinology.

[37]  F. Holsboer,et al.  Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. , 1985, Life sciences.

[38]  H. Gainer,et al.  Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles , 1985, Nature.

[39]  G. Gillies,et al.  Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro. , 1984, The Journal of endocrinology.

[40]  S. Lamberts,et al.  Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. , 1984, The Journal of clinical endocrinology and metabolism.

[41]  M. Forsling,et al.  Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[42]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[43]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[44]  G. Raisman,et al.  Sexual dimorphism in the neuropil of the preoptic area of the rat and its dependence on neonatal androgen. , 1973, Brain research.

[45]  R. Walter,et al.  Plasma Corticosteroids: Changes in Concentration after Stimulation of Hippocampus and Amygdala , 1963, Science.

[46]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[47]  K. Takahashi,et al.  Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. , 1993, Neuroendocrinology.

[48]  S. Makino,et al.  Cerebrospinal fluid and plasma corticotropin-releasing hormone in senile dementia. , 1991, Life sciences.

[49]  I. Heuser,et al.  Pathophysiology of hypothalamic-pituitary-adrenal axis function in depression , 1991 .

[50]  J. Kiss,et al.  Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. , 1986, Neuroendocrinology.

[51]  Elliott I. Organick,et al.  Computer Science, A First Course. , 1971 .